Cite
HARVARD Citation
Ferreri, A. et al. (2017). Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial. Lancet. 4 (3), pp. e137-e146. [Online].